doi: 10.1161/hq1201.100223
© 2001 American Heart Association, Inc.
Atherosclerosis and Lipoproteins |
Long-Term Homocysteine-Lowering Treatment With Folic Acid Plus Pyridoxine Is Associated With Decreased Blood Pressure but Not With Improved Brachial Artery Endothelium-Dependent Vasodilation or Carotid Artery Stiffness
A 2-Year, Randomized, Placebo-Controlled Trial
From the Institute for Cardiovascular Research Vrije Universiteit (R.A.J.M.v.D., J.A.R., M.S., J.W.R.T., C.D.A.S.) and Department of Internal Medicine (R.A.J.M.v.D., M.S., C.D.A.S.), University Hospital Vrije Universiteit, Department of Surgery (J.A.R.), University Hospital Vrije Universiteit, and Institute for Research in Extramural Medicine (J.W.R.T.), Vrije Universiteit, Amsterdam, Netherlands.
Reprint requests to Professor Coen D.A. Stehouwer, University Hospital Vrije Universiteit, Department of Internal Medicine, De Boelelaan 1117, 1081 HV Amsterdam, Netherlands, and PO Box 7057, 1007 MB Amsterdam, Netherlands. E-mail cda.stehouwer{at}vumc.nl
Homocysteine is associated with atherothrombotic disease, which may be mediated through associations of homocysteine levels with blood pressure, endothelial function, or arterial stiffness. In a placebo-controlled, randomized clinical trial, we measured blood pressure, brachial artery endothelium-dependent vasodilation, and common carotid artery stiffness in 158 clinically healthy siblings of patients with premature atherothrombotic disease at baseline and after 1 and 2 years of homocysteine-lowering treatment with folic acid (5 mg) plus pyridoxine (250 mg). Intention-to-treat analyses limited to participants (n=130) who underwent at least 1 measurement after the baseline visit showed that compared with placebo, treatment with folic acid plus pyridoxine was associated with a 3.7-mm Hg (95% CI -6.8 to -0.6 mm Hg) lower systolic and a 1.9-mm Hg (95% CI -3.7 to -0.02 mm Hg) lower diastolic blood pressure over the 2-year trial period. Together with the decreased occurrence of abnormal exercise electrocardiography tests reported previously, our results support the hypothesis that homocysteine-lowering treatment with folic acid plus pyridoxine has beneficial vascular effects. Because no effects could be demonstrated on brachial artery endothelium-dependent vasodilation or on common carotid artery stiffness, the present study does not support the hypothesis that the cardiovascular effects of homocysteine are mediated through these factors, at least in clinically healthy individuals.
Key Words: homocysteine • blood pressure • common carotid artery stiffness • brachial artery flow-mediated vasodilation • folic acid • pyridoxine
This article has been cited by other articles:
 |
|
 |
|
  J. P. Forman, M. J. Stampfer, and G. C. Curhan Diet and Lifestyle Risk Factors Associated With Incident Hypertension in Women JAMA, July 22, 2009; 302(4): 401 - 411. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Antoniades, A. S. Antonopoulos, D. Tousoulis, K. Marinou, and C. Stefanadis Homocysteine and coronary atherosclerosis: from folate fortification to the recent clinical trials Eur. Heart J., January 1, 2009; 30(1): 6 - 15. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. de Bree, L. A van Mierlo, and R. Draijer Folic acid improves vascular reactivity in humans: a meta-analysis of randomized controlled trials Am. J. Clinical Nutrition, September 1, 2007; 86(3): 610 - 617. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. Abularrage, A. N. Sidawy, P. W. White, G. Aidinian, K. J. DeZee, J. M. Weiswasser, and S. Arora Effect of Folic Acid and Vitamins B6 and B12 on Microcirculatory Vasoreactivity in Patients With Hyperhomocysteinemia Vascular and Endovascular Surgery, September 1, 2007; 41(4): 339 - 345. [Abstract] [PDF]
|
|
|
|
 |
|
 D. Levy, S.-J. Hwang, A. Kayalar, E. J. Benjamin, R. S. Vasan, H. Parise, M. G. Larson, T. J. Wang, J. Selhub, P. F. Jacques, et al. Associations of Plasma Natriuretic Peptide, Adrenomedullin, and Homocysteine Levels With Alterations in Arterial Stiffness: The Framingham Heart Study Circulation, June 19, 2007; 115(24): 3079 - 3085. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. McMahon, C. M. Skeaff, S. M. Williams, and T. J. Green Lowering Homocysteine with B Vitamins Has No Effect on Blood Pressure in Older Adults J. Nutr., May 1, 2007; 137(5): 1183 - 1187. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. E. Mullick, U. B. Zaid, C. N. Athanassious, S. R. Lentz, J. C. Rutledge, and J. D. Symons Hyperhomocysteinemia increases arterial permeability and stiffness in mice Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2006; 291(5): R1349 - R1354. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. H. Bonaa, I. Njolstad, P. M. Ueland, H. Schirmer, A. Tverdal, T. Steigen, H. Wang, J. E. Nordrehaug, E. Arnesen, K. Rasmussen, et al. Homocysteine Lowering and Cardiovascular Events after Acute Myocardial Infarction N. Engl. J. Med., April 13, 2006; 354(15): 1578 - 1588. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Symons, U. B. Zaid, C. N. Athanassious, A. E. Mullick, S. R. Lentz, and J. C. Rutledge Influence of Folate on Arterial Permeability and Stiffness in the Absence or Presence of Hyperhomocysteinemia Arterioscler Thromb Vasc Biol, April 1, 2006; 26(4): 814 - 818. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J Stott, G. MacIntosh, G. D. Lowe, A. Rumley, A. D McMahon, P. Langhorne, R C. Tait, D. S. J O'Reilly, E. G Spilg, J. B MacDonald, et al. Randomized controlled trial of homocysteine-lowering vitamin treatment in elderly patients with vascular disease Am. J. Clinical Nutrition, December 1, 2005; 82(6): 1320 - 1326. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Tawakol, R. Q. Migrino, K. S. Aziz, J. Waitkowska, G. Holmvang, N. M. Alpert, J. E. Muller, A. J. Fischman, and H. Gewirtz High-Dose Folic Acid Acutely Improves Coronary Vasodilator Function in Patients With Coronary Artery Disease J. Am. Coll. Cardiol., May 17, 2005; 45(10): 1580 - 1584. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Forman, E. B. Rimm, M. J. Stampfer, and G. C. Curhan Folate Intake and the Risk of Incident Hypertension Among US Women JAMA, January 19, 2005; 293(3): 320 - 329. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Suliman, P. Barany, K. Kalantar-Zadeh, B. Lindholm, and P. Stenvinkel Homocysteine in uraemia--a puzzling and conflicting story Nephrol. Dial. Transplant., January 1, 2005; 20(1): 16 - 21. [Full Text] [PDF]
|
|
|
|
|
|
Q. Xu, M. Sata, and R. Nagai Mouse Models of Vein Grafts Arterioscler Thromb Vasc Biol, November 1, 2004; 24(11): e185 - e187. [Full Text] [PDF]
|
|
|
|
 |
|
 E. M. Wrone, J. M. Hornberger, J. L. Zehnder, L. M. McCann, N. S. Coplon, and S. P. Fortmann Randomized Trial of Folic Acid for Prevention of Cardiovascular Events in End-Stage Renal Disease J. Am. Soc. Nephrol., February 1, 2004; 15(2): 420 - 426. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Sundstrom, L. Sullivan, R. B. D'Agostino, P. F. Jacques, J. Selhub, I. H. Rosenberg, P. W.F. Wilson, D. Levy, and R. S. Vasan Plasma Homocysteine, Hypertension Incidence, and Blood Pressure Tracking: The Framingham Heart Study Hypertension, December 1, 2003; 42(6): 1100 - 1105. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Lim and P. A. Cassano Homocysteine and Blood Pressure in the Third National Health and Nutrition Examination Survey, 1988-1994 Am. J. Epidemiol., December 15, 2002; 156(12): 1105 - 1113. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Weiss, C. Keller, U. Hoffmann, and J. Loscalzo Endothelial dysfunction and atherothrombosis in mild hyperhomocysteinemia Vascular Medicine, August 1, 2002; 7(3): 227 - 239. [Abstract] [PDF]
|
|